The EU-funded project REBECCA taps into the potential of Real-World Data to support clinical research and to improve existing clinical workflows.
It will combine clinical data with data obtained from multiple wearable, online behaviour and registry data to study the complex array of chronic comorbidities developed during breast cancer recovery. The data will be deployed within 7 clinical studies in 3 countries, involving over 650 individuals, and it will help shape future guidelines and practices for post-cancer treatment.
Sign up to our newsletter
Sign up for our mailing list to receive occasional emails as we publish key project materials and commission new strands of work.
More impact of clinical research on breast cancer patients
Clinical and technological universities, industry leaders, public health experts, and patient associations will work together to shape guidelines and practices for post-cancer treatment. Best practices from the REBECCA studies will be disseminated to researchers, public health and regulatory bodies throughout Europe to facilitate wider adoption of RWD in clinical research.
REBECCA will provide an infrastructure for continued progress on the use of RWD beyond the project, facilitating the mass adoption of RWD as a valuable clinical research and patient management tool.
Find Out More
How we will do it
Our work packages are evolving, but include consideration and development of:
Find out about the latest REBECCA related news.
Collecting preliminary data from breast cancer patients to help shape the REBECCA mobile app
In November, Breast Cancer Society AMAZONA, one of the REBECCA partners, reached out to its members, breast cancer patients who have undergone primary treatment, to fill out a survey to collect the data needed for the development of the REBECCA mobile application. The data collected will be used …
Dr Ioannis Sarafis presents the REBECCA project at the EHMA PIE session on Improving healthcare access and outcomes
Dr Ioannis Sarafis, a postdoctoral researcher at the Aristotle University of Thessaloniki – the REBECCA project leader, represented REBECCA with an EHMA PIE presentation at the EHMA 2021 Annual Conference. The presentation titled Moving beyond RCTs: Tapping the potential of Real-World Data for ad…
Izabela Grape underlines the importance of utilising patient engagement
Ms Izabela Grape, Chairwoman of Breast Cancer Society Amazona, spoke at the Plenary Session on Leadership for the Future of Healthcare at the EHMA 2021 Annual Conference, held digitally from 15-17 September 2021. Grape, who is a two-time breast cancer survivor, opened the session by sharing her p…
The project brings together 12 partners from 7 European countries. Clinical and technological universities, industry leaders, public health experts, and patient associations will work together to shape guidelines and practices for post-cancer treatment.